BIOS - BioScrip, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue935,589982,223922,654
Cost of Revenue669,958721,308671,901
Gross Profit265,631260,915250,753
Operating Expenses
Research Development---
Selling General and Administrative199,493208,522215,866
Non Recurring42,658317,297109,753
Total Operating Expenses---
Operating Income or Loss1,929-287,647-97,809
Income from Continuing Operations
Total Other Income/Expenses Net3,9543,9543,954
Earnings Before Interest and Taxes5,883-287,647-97,809
Interest Expense38,23537,31340,918
Income Before Tax-32,352-324,960-138,727
Income Tax Expense2,015-21,53211,193
Minority Interest---
Net Income From Continuing Ops-34,367-303,428-149,920
Non-recurring Events
Discontinued Operations-7,1393,7212,452
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-41,506-299,707-147,468
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-50,590-309,517-147,468